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Abstract 
 
Failures in antibiotic treatments for bacterial infections are typically attributed to 
antibiotic resistance. However, it has long been realised that bacteria can also 
employ other mechanisms to aid survival in the presence of antibiotics. Indeed, 
some bacterial cells react to the presence of antimicrobial drugs by blocking or 
retarding growth. These cells are named persister cells and can survive 
bactericidal antibiotics that require active growth for killing. This property is known 
as “persistence”. 
Increasing evidence suggests a link between specific environmental conditions 
and the development of persistence.  
In this study, the temporal windows during the growth cycle when the fraction of 
persisters to β-lactams, quinolones or aminoglycoside increases have been 
investigated. Our results confirmed that the environment plays a significant role 
in persister cell formation. Indeed, cells treated with antibiotics but without fresh 
media, regrow at a higher density than the cells in the nutrient-rich environment. 
Nowadays classic microbiological approaches are not sufficient for the study of 
persister cells, since the persister frequency is often low and dynamic changes in 
phenotype cause cells to switch between the persister and normal phenotype. 
Over the past decade, microfluidic techniques have gained increasing interest in 
the research community. Integrated micro- and nanofluidic lab-on-a-chip systems 
able to handle samples in a picoliter range are now available, and are certain to 
become an everyday item in biotechnology and biomedicine within a few years. 
Here we present a novel microfluidic-microscopy assay for the study of persister 
cell formation under controlled delivery of antibiotics. Our device is fabricated 
from polydimethylsiloxane, PDMS, and is able to trap single cells. The microfluidic 
setup has been integrated with a microscope in order to obtain high-resolution 
imaging and quantitatively measure growth and shape changes of large numbers 
of individual cells. Our device allowed us to challenge a culture of E. coli with 
three different antibiotics, and record the individual response of thousands of 
bacteria. When fresh media was given we distinguished not only dividing cells, 
as per classic microbiological techniques, but also two further phenotypes: 
elongating and non-growing. 
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Furthermore, a preliminary study has been conducted regarding the possibility of 
combining DNA-PAINT with microfluidics for the future investigation of persister 
cells, with sub-cellular resolution. Together, the results from this thesis enable 
future investigations, with the goal of advancing our understanding of persistence 
in response to antibiotics. 
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1. Introduction 
 
The discovery of antibiotics dates back to 1941 and is considered one of the most 
significant milestones in modern medicine (Cruickshank et al., 2014). In the last 
70 years, the treatment of infectious disease has witnessed an extraordinary 
reduction in the morbidity and mortality mostly due to the rapid development of 
safe and effective antibiotic drugs. Seen initially as truly miraculous drugs, access 
to the first available systemic antibiotics (sulphonamides and penicillin) was not 
immediately available to the public (Alanis, 2005). In fact, these drugs were 
scarce, very expensive and were initially reserved for use by the military during 
World War II (Lerner, 2004). As more antibiotics were discovered, manufacturing 
processes were simplified, and newer formulations developed. Access to 
antibiotics then eased considerably, and their use became widespread (Alanis, 
2005).  
However, in an interview with The New York Times in 1945, Sir Alexander 
Fleming already warned that the inappropriate use of penicillin could lead to the 
selection of resistant ‘‘mutant forms’’ of Staphylococcus aureus. Indeed, the first 
resistant organisms appeared in 1940 in the form of a Balantidium coli strain able 
to produce an enzyme to disrupt penicillin activity (Abraham & Chain, 1940). 
Furthermore, in the early 1950s, due to the widespread use of this antibiotic, a 
significant number of strains of S. aureus became resistant to penicillin 
(Appelbaum, 2006; Ainsa, 2002). Unfortunately, things have not improved in the 
recent past; every day more bacteria, previously susceptible to common 
antimicrobials, are reported to have acquired mutations making them resistant to 
different antibiotics (Alanis, 2005). 
However, it is known that some bacteria can avoid killing by certain antibiotics 
without the mutation. In 1944 Joseph Bigger observed that S. aureus could 
survive extensive antibiotic treatments without acquiring a single resistance 
mutation. This phenomenon has been called ‘tolerance’ (Horne & Tomasz, 1977) 
or ‘persistence’ (Bigger, 1944). These terms were coined to distinguish these 
modes of survival from 'resistance' and have often been used interchangeably in 
the literature. However, more recently tolerance and persistence have been 
classified as two different phenomena (Brauner et al., 2016). To briefly 
summarise why: tolerance and persistence have several common traits, both 
terms describe a phenotypic variant of susceptible cells which are able to survive 
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the exposure to high concentrations of antibiotic drugs. Both tolerant and 
persistent cells are able to re-initiate growth after the drug treatments end. 
However, Brauner et al. describe the difference being that tolerance generates 
across an entire bacterial population, while persistence is, by definition, 
characteristic of a small subpopulation (usually <0.001%) (Brauner et al., 2016).  
One further mode in which bacterial cells escape stressful conditions is by 
adopting a viable but not culturable (VBNC) state. Discovered in the 80s (Xu et 
al., 1982) the VBNC state has been described as a “non recoverable state of 
existence”. Indeed, VBNC cells, despite being metabolically active at low levels, 
do not re-initiate growth, even when exposed to ideal conditions. 
 
More details about tolerance, persistence and the VBNC state are described in 
the section below. 
 
1.1 Drug resistance, tolerance and persistence 
1.1.1 Resistance 
 
The term antibiotic resistance is used to describe the heritable ability of 
microorganisms to grow at high concentrations of an antibiotic (Scholar & Pratt, 
2000), irrespective of the duration of treatment. Resistance can be quantified by 
the minimum inhibitory concentration (MIC) of a particular antibiotic. The MIC is 
measured by exposing a bacterial population to increasing concentrations of the 
antibiotic. This allows the measurement of the minimum concentration at which 
growth is not detected. The MIC for a bacterial strain resistant to an antibiotic is 
substantially higher than the MIC for an antibiotic-susceptible strain (Brauner et 
al., 2016). Resistance mechanisms have been studied for a long time and are 
generally well understood (Eliopoulos et al., 1986; Payne et al., 2007). Fig 1.1 
depicts five representative mechanisms. 
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Fig 1.1: A schematic representation of different mechanisms of resistance. 1) restricted 
penetration and/or efflux of the drug; 2) destruction or inactivation of the antibiotic; 3) 
overproduction of the antibiotic target; 4) generation of an alternative pathway to avoid 
the negative antibiotic effect; 5) target modification. Image adapted from Lewis, 2013. 
 
Some bacteria react to antibiotic challenge by the destruction of the antibiotic 
molecules (for example, by β-lactamases) or target modification (for example, a 
mutation in the 30S ribosomal protein RpsL confers resistance to streptomycin). 
An alternative resistance mechanism relies on limited penetration and/or efflux of 
the drug (Alekshun & Levy, 2007; Walsh, 2003). Furthermore, antibiotic-resistant 
bacteria are then able to transfer copies of DNA that code for a mechanism of 
resistance to other bacterial cells, making resistance genes hereditary and 
transferable, even across distantly related bacteria (Hussain, 2015).This process 
is called horizontal gene transfer and allows the DNA of resistance genes to 
spread rapidly across different species. 
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1.1.2 Tolerance 
 
The term tolerance is used to describe the ability of a microorganism population 
to survive short exposure to high concentrations of drugs. Tolerance is typically 
achieved through the slowing down of a bacterial cell’s metabolic processes. This 
can affect the action of all antibiotics which act on growing cells (e.g. β-lactam, 
fluoroquinolone). Tolerant cells do not carry mutations. However, some studies 
argue that tolerance can be inherited, as is the case for bacterial species which 
are inherently slow growing (Brauner et al., 2016). Tolerant bacteria are able to 
survive at antibiotic concentrations far higher than the MIC and can re-initiate 
growth when an antibiotic treatment ends (Fridman et al., 2014). Drug tolerance 
is, therefore, a relevant descriptor of response to bactericidal antibiotics but is not 
applicable to drugs that solely inhibit bacterial growth, without killing (Kester & 
Fortune, 2014).  
When a population of bacteria develops tolerance, there is no change in the MIC; 
the only difference is the period required for the drugs to achieve the bactericidal 
effect. Therefore, a useful parameter to study tolerance is the minimum duration 
of treatment that is necessary to kill 99% of a bacterial population (MDK99) 
(Fridman et al., 2014). If antibiotic treatment is interrupted before the MDK99, cell 
growth will resume, returning to its original level. 
 
1.1.3 Persistence 
 
As mentioned before, the key difference between drug tolerance and persistence 
is that drug tolerance originates in a whole population of bacterial cells while 
persistence is a characteristic to only a small subpopulation of cells, named 
persister cells. Persister cells are not mutants; they are phenotypic variants 
produced stochastically in the population. The relative abundance of persister 
cells is less than the 0.01% of the total population (Keren et al., 2004).  
Like tolerant cells, persister cells have the ability to spontaneously switch back to 
the normal, nonpersistent state and regain their usual sensitivity to antibiotics. 
Upon turning back, they are indistinguishable from normal cells (Kussell et al., 
2005). Therefore, persister cell progenies are as sensitive to a drug as the parent 
culture from which the persister was derived (Lewis, 2010; Moyed & Bertrand, 
1983; Peng et al., 2016). The mechanisms of persister cell formation have been 
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at the centre of several recent reviews (Balaban et al., 2013; Maisonneuve & 
Gerdes, 2014; Harms et al., 2016).  
While bacterial persistence is non inherited, the propensity to form persister cells 
is a genetically evolved trait ( Kussell & Leibler, 2005). Indeed, in 1983 Moyed 
and Bertrand were able to generate a stable hip (high persisters) mutant through 
the intermittent application of high doses of bactericidal antibiotics to a population 
of chemically mutagenized Escherichia coli K12 (Moyed & Bertrand, 1983). 
The E. coli mutants were found to have mutations in the hipBA toxin-antitoxin 
(TA) module, which encodes HipA, a toxin, and its cognate antitoxin, HipB.  
HipA inactivates an essential amino-acyl tRNA synthetase, owing to the 
accumulation of uncharged tRNAs (Wen et al., 2017). 
Generally, TA modules code for two components, a stable toxin that inhibits cell 
growth and a labile antitoxin that counteracts toxin activity. Under normal growth 
conditions, antitoxins potently inhibit the activities of their toxins. In contrast, 
during stress, the antitoxins are degraded, allowing the toxins to interfere and 
block DNA replication and protein translation. This inhibition results in rapid 
growth arrest. When HipA is expressed above a threshold set by the abundance 
of HipB, a stringent response is induced which leads to the induction of a transient 
growth arrest. Gerdes and colleagues proposed a molecular mechanism for 
stochastic persister cell formation through the action of TA modules (Fig. 1.2). 
This shows that the level of guanosine pentaphosphate (p)ppGpp) varies 
stochastically in a population of exponentially growing cells and that the high 
(p)ppGpp level in rare cells induces slow growth and persistence. (p)ppGpp 
triggers slow growth by activating toxin-antitoxin modules through a regulatory 
cascade, depending on inorganic polyphosphate and Lon protease that degrades 
antitoxins. This causes the liberation of their cognate toxins, which inhibit 
translation and thereby induce persistence (Maisonneuve et al., 2013). 
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Fig.1.2: Persister cell formation mechanism. 1) Activation of RelA or SpoT causes an 
increase in intracellular (p)ppGpp levels, 2) resulting in the inhibition of 
exopolyphosphatase (PPX), the enzyme that degrades PolyP. 3) This results in 
accumulation of PolyP as a result of the constitutive activity of polyphosphate kinase 
(PPK). 4) Lon protease is activated by PolyP and begins to degrade antitoxins. 5) Free 
toxins inhibit translation and cause cells to enter growth arrest and persistence. Image 
adapted from Ayrapetyan et al., 2015. 
 
The presence of persister cells can be easily detected by the “biphasic killing” of 
bacterial cultures exposed to bactericidal antibiotics (Fig 1.3).  
15 
 
Fig.1.3: A lethal dose of bactericidal antibiotic added at time zero rapidly eradicates the 
sensitive bulk of the population (blue) until only non-growing persister cells (red) that are 
killed at a slower rate remain. The termination of antibiotic treatment enables the 
population to be replenished by regrowth of surviving persister cells. Image adapted from 
Harms et al., 2016. 
 
After an initial, rapid drop in bacterial counts caused by the effect of the antibiotic 
on the majority of the cells, the cells are able to initiate a new growth phase when 
antibiotic concentrations fall (Levin & Rozen, 2006; Harms et al., 2016). In 2004, 
Balaban and co-workers investigated the formation of persister cells using a 
microfluidic device, following the response of single cells to drug treatments, 
whilst entrapped in narrow channels (Balaban et al., 2004). Their study identified 
two types of persister cells: Type I and Type II. Type I persister cells were 
generated during the stationary growth phase in response to one or more external 
triggers. Possible trigger events include starvation, oxidative stress, DNA 
damage, stressful pH, antibiotics, and interactions with a pathogen (Maisonneuve 
& Gerdes, 2014).  
In contrast, Type II persister cells were produced continuously during growth. 
Here, a small portion of the cell population remains in a dormant phase, where 
almost all cell functions are suppressed. This strategy, defined as bet-hedging 
(Dubnau & Losick, 2006),  gives the bacterial population an evolutionary 
advantage for survival in a changing environment (Maisonneuve & Gerdes, 
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2014). Both types of persistence represent a threat to human health, and despite 
being known for a long time, effective strategies for contrasting these cells are 
still missing. 
 
1.1.4 Viable but non-culturable state 
 
In 1982 Rita Colwell’s team described E. coli and Vibrio cholera cells for the first 
time to be in a “non-recoverable stage of existence”, that remained viable hence 
metabolically active despite not growing nor dividing (Xu et al., 1982).  
Since their discovery at least 85 species of bacteria have been found to enter a 
mode of dormancy referred to as the viable but non-culturable (VBNC) state 
(Pinto et al., 2015). Viable but non-culturable (VBNC) bacteria are non-dividing 
cells that possess low metabolic activity in response to environmental stresses 
(Kedzierska & Hayes, 2016), including starvation, extreme temperature, low 
oxygen level and antibiotic exposure (Pinto et al., 2015). 
VBNC cells are reported to be viable due to their intact cell membranes, low-level 
metabolic activity, and continued gene expression. However, they are 
nondividing and, unlike persister cells, unable to immediately regain the ability to 
divide when plated on routine laboratory medium. It is worth noticing that both 
cell types can regrow or resuscitate, ultimately giving rise to a growing population 
(Ramamurthy et al., 2014). 
Despite being closely related, VBNC and persister cells present some 
differences. VBNC cells are formed after longer periods of incubation in 
environmental conditions that do not sustain growth (Ramamurthy et al., 2014), 
while persister cells are formed during growth, albeit at a low frequency (Pinto et 
al., 2015). However, a recent study (Ayrapetyan et al., 2015) revealed that VBNC 
cells can exist together with persister cells in unstressed growing cultures, leading 
to the hypothesis that they form stochastically, with a mechanism similar to Type 
II persister cells. 
Furthermore, changes in the morphology of VBNC cells are extensively 
documented, as reviewed by Pinto et al., 2015, but no such morphological 
changes have been reported for persister cells.  
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1.2 Classes of antibiotics 
 
An antibiotic is an agent that either kills or inhibits the growth of a microorganism. 
Antibacterial antibiotics are commonly classified based on their chemical 
structure, mechanism of action, or spectrum of activity. Most antibiotics target 
bacterial functions or growth processes. Bactericidal antibiotics can target the 
bacterial cell wall (penicillins and cephalosporins), the cell membrane 
(polymyxins) or essential bacterial enzymes (quinolones, and sulfonamides). 
Antibiotics that target the protein synthesis mechanism (macrolides, 
lincosamides, and tetracyclines) are usually bacteriostatic (except bactericidal 
aminoglycosides). Figure 1.4 shows the different targets of the major 
antimicrobial chemoterapic agents. 
 
Fig.1.4: Mode of action of the major antimicrobial chemoterapic agents. There are five 
main antibacterial drug targets in bacteria: cell-wall synthesis, DNA gyrase, metabolic 
enzymes, DNA-directed RNA polymerase and protein synthesis. The figure shows the 
antimicrobial agents that are directed against each of these targets. Figure adapted from 
(Lewis, 2013). 
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The first antibiotics developed were penicillin and streptomycin, these are both 
still in use today. Penicillin is now in a class of antibiotics known as the penicillins, 
which also includes the more recently developed antibiotics ampicillin, 
flucloxacillin, and methicillin. These antibiotics inhibit the synthesis of the 
bacterial cell walls, leading to cell lysis and death. Streptomycin is now in the 
aminoglycoside class of antibiotics, which also contains gentamicin, kanamycin, 
and netromycin. These antibiotics bind to the 30s subunit of the bacterial 
ribosome, preventing the synthesis of new proteins. Aminoglycosides are 
effective against gram-negative bacteria such as Pseudomonas aeruginosa and 
E. coli, but they are not active against anaerobic bacteria. Another class of 
antibiotics that similarly inhibit peptidoglycan synthesis to penicillins is 
glycopeptides. These antibiotics bind to the amino acids within a cell wall, 
preventing the addition of new units to peptidoglycan.  
Cephalosporins are a broad class of antibiotics. The earliest cephalosporin was 
isolated by an Italian scientist in 1948 (Partridge, 2009), from bacteria growing in 
Sardinia. This class of antibiotics has the same mode of action as other β-lactam 
antibiotics (such as penicillins), but are less susceptible to β-lactamases. 
Cephalosporins prevent the proper production of a bacterial cell wall by disrupting 
the synthesis of the peptidoglycan layer forming the cell wall. Early 
cephalosporins were only active against a few gram-negative bacteria, however, 
second to fifth generation cephalosporin antibiotics have been designed by 
biochemists to be effective against a wider range of bacteria. The most recently 
developed can be used to treat infections caused by gram-positive as well as 
gram-negative bacteria. 
In contrast to the antibiotics mentioned above, tetracyclines and macrolide 
antibiotics act on the bacterial ribosome. Tetracyclines are protein synthesis 
inhibitors, blocking the binding of aminoacyl-tRNA to the mRNA-
ribosome complex, mainly by binding to the 30S ribosomal subunit in the mRNA 
translation complex (Chukwudi, 2016). 
Erythromycin is probably the most well-known of the macrolide antibiotics, a class 
which also includes clarithromycin and telithromycin. These inhibit bacterial 
protein biosynthesis by binding reversibly to the subunit 50S of the bacterial 
ribosome, thereby inhibiting translocation of peptidyl tRNA. 
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Quinolones and fluoroquinolones are chemotherapeutic bactericidal drugs, which 
interfere with DNA replication. Both act by inhibiting the bacterial DNA gyrase or 
the topoisomerase II enzyme, thereby inhibiting DNA replication and transcription 
(further detail on this is available in section 1.3.3). 
In this study antibiotics from three different classes have been used: a β-lactam, 
an aminoglycoside, and a fluoroquinolone. 
 
1.3 Antibiotics used in this study 
1.3.1 Ampicillin 
 
Ampicillin is a β-lactam antibiotic used to prevent and treat a number of bacterial 
infections, such as respiratory tract infections, urinary tract infections, meningitis, 
salmonellosis, and endocarditis. Ampicillin was developed in 1961 (Fischer & 
Robin Ganellin, 2006) and it is on the World Health Organization's (WHO) List of 
Essential Medicines, deemed to be the most important medications needed in a 
basic health system (World Health Organization, 2013). Ampicillin falls within 
the penicillin group of β-lactam antibiotics and is part of 
the aminopenicillin family. It is able to penetrate Gram-positive and some Gram-
negative bacterial cells. Ampicillin acts as an irreversible inhibitor of 
transpeptidase, a bacterial cell wall biosynthetic enzyme (Finberg et al., 2012). It 
inhibits the third and final stage of cell wall synthesis, binary fission, which 
ultimately leads to cell lysis (Fig 1.5); thus ampicillin is usually bacteriolytic 
(American Hospital Formulary Service Drug Information, 2006; Finberg et al., 
2012). 
As for other β-lactams, the cellular target of ampicillin is peptidoglycan (PG). This 
thin layer of biopolymer mesh, which serves to maintain cell morphology and 
balance turgor pressure. It is composed of long glycan chains and peptide cross-
links (Holtje, 1998). Peptide cross-links are formed by the transpeptidase activity 
of penicillin-binding proteins (PBPs). Ampicillin covalently binds to PBPs and 
inhibits the formation of cross-links, the final stage of PG synthesis (Tipper & 
Strominger, 1965).  
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Fig. 1.5: Ampicillin inhibits transpeptidation by binding to penicillin-binding proteins 
(PBPs) on maturing peptidoglycan strands. The decrease in peptidoglycan synthesis and 
increase in autolysins leads to lysis and cell death (image adapted from Kohanski, 
Dwyer, and Collins 2010). 
Inhibition of PG synthesis by β-lactams has various effects on cell shape, as  
PBPs are involved in cell division, elongation, and shape maintenance (Spratt, 
1975). It has been proposed that inhibition of cross-link formation by β-lactams 
combined with misregulated cell wall degradation by PG hydrolases results in an 
accumulation of PG defects, which ultimately leads to cell lysis (Chung et al., 
2009). 
 
1.3.2 Gentamicin 
 
Gentamicin belongs to the aminoglycoside antibiotic family, which is known to be 
clinically effective in the treatment of most gram-negative aerobic and facultative 
anaerobic bacilli infections, exerting both a bacteriostatic and bactericidal effect 
(Hathorn et al., 2014). However, it does not show activity against gram-negative 
anaerobes and most gram-positive bacteria (Levison, 2012). Aminoglycosides 
are most effective against bacteria populations that are rapidly multiplying 
(Boothe, 2012). These activities are attributed to a primary mode of action such 
as protein synthesis inhibitors. The inhibition of protein synthesis by 
aminoglycosides is mediated through energy-dependent binding to the cytosolic, 
membrane-associated bacterial ribosome (Mingeot-Leclercq et al., 1999). 
Aminoglycosides first cross bacterial cell walls (lipopolysaccharide in gram-
negative bacteria) and cell membranes, where they are actively transported 
(Boothe, 2012). Aminoglycoside presence in the cytosol generally inhibits peptide 
elongation at the 30s ribosomal subunit, giving rise to inaccurate mRNA 
translation and therefore biosynthesis of proteins that are truncated (Fig.1.6), or 
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bear altered amino acid compositions at particular points (Mingeot-Leclercq et 
al., 1999).  
 
Fig. 1.6: Aminoglycosides bind to the 30S subunit of a ribosome and cause 
misincorporation of amino acids into elongating peptides. These mistranslated proteins 
can misfold; incorporation of misfolded membrane proteins into the cell envelope leads 
to increased drug uptake. This, together with an increase in ribosome binding, has been 
associated with cell death (image adapted from Kohanski, Dwyer, and Collins 2010). 
Specifically, binding impairs translational proofreading, leading to a misreading 
of the RNA message, premature termination, or both, and so to the inaccuracy of 
the translated protein product. Proteins misfolded as a result of this are then 
incorporated into the bacterial cell membrane, which may lead to changes in its 
permeability, thus enabling further aminoglycoside uptake (Mingeot-Leclercq et 
al., 1999). The drug’s action ends with cell death, caused by the loss of structural 
integrity in the cell membrane (Boothe, 2012). 
 
1.3.3 Ofloxacin 
Ofloxacin is a synthetic antibiotic of the second-generation fluoroquinolone drug 
class (Kawahara, 1998; Nelson et al., 2007). The fluoroquinolones represent an 
expanding class of broad-spectrum antibacterial drugs, which target a wide range 
of Gram-negative and anaerobic species. These bacteria are responsible for 
many infections, in particular in the ocular region (Hooper, 1999; Smith et al., 
2001; Zechiedrich & Cozzarelli, 1995). Fluoroquinolones act by inhibiting two 
enzymes involved in bacterial DNA synthesis, both of which are DNA 
topoisomerases. These enzymes are not present in human cells and are 
essential for bacterial DNA replication, thereby enabling these agents to be both 
specific and bactericidal. Specifically, fluoroquinolones inhibit DNA gyrase and 
topoisomerase IV. DNA gyrase introduces negative super-helical twists in the 
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bacterial DNA double helix ahead of the replication fork, thereby catalysing the 
separation of daughter chromosomes (Fig. 1.7). 
 
 
 
 
 
 
 
 
Fig. 1.7: Drug-target interactions and associated cell death mechanisms. Quinolone 
antibiotics interfere with changes in DNA supercoiling by binding to topoisomerase II or 
topoisomerase IV. This leads to the formation of double-stranded DNA breaks and cell 
death in either a protein synthesis-dependent or protein synthesis-independent manner 
(image adapted from Kohanski, Dwyer, and Collins 2010). 
This mechanism is essential for the initiation of DNA replication and allows for 
binding of initiation proteins (Blondeau, 1999; Pan & Fisher, 1997). 
Topoisomerase IV is responsible for decatenation, removing the links between 
chromosomes, thereby allowing segregation into two daughter cells at the end of 
a round of replication (Zechiedrich & Cozzarelli, 1995). Fluoroquinolones interact 
with the enzyme-bound DNA complex (i.e., DNA gyrase with bacterial DNA or 
topoisomerase IV with bacterial DNA) to create conformational changes that 
result in the inhibition of normal enzyme activity. As a result, the drug-enzyme-
DNA complex blocks progression of the replication fork, thereby inhibiting normal 
bacterial DNA synthesis and ultimately resulting in rapid bacterial cell death 
(Kampranis & Maxwell, 1998; Marians & Hiasa, 1997).  
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1.4 Application of microfluidics in microbiology 
 
Microfluidics allows the control and manipulation of fluids contained in small 
(generally 10–100 μm) channels, where fluid flow is dominated by surface tension 
and laminar effects (Saleh-Lakha & Trevors, 2010). Microfluidic technologies 
provide a platform for combining the simplicity of fluidic diffusion with the 
quantitative measurement of dilutions. 
The origin of microfluidic devices is associated with the late 1960s. The first 
microfluidic device was a prototype of a quadrupole gas chromatograph-mass 
spectrometer (GC/MS) by Finnigan Instrument Corporation, who sold it to 
Stanford and Purdue University. This first instrument cost 100,000 USD, and was 
controlled by a mini-computer (Brock, 2011). 
In 1993, Andreas Manz published a pioneering article describing the fabrication 
of a miniaturised capillary electrophoresis-based chemical analysis system on a 
chip (Harrison et al., 1993). Only one year after the publication of Manz’s work, 
the first International Conference on Micro-Total Analysis Systems took place in 
Enschede, the Netherlands, as a forum for reporting the latest research in the 
field of microfluidics, including: Lab-on-a-Chip, microfabrication, nanotechnology, 
integration and detection technologies for life sciences and chemistry.  
Professor George Whitesides, one of the major and more active pioneers of 
microfluidics as a technique, published an article in 1998 on the rapid prototyping 
of microfluidic systems in polydimethylsiloxane (PDMS). This publication 
described the design and fabrication of microfluidic chips for capillary 
electrophoresis in a transparent, elastomeric material. Such chips could be made 
in less than a day using high-resolution printing, contact lithography, moulding of 
PDMS, and contact sealing of oxidised PDMS surfaces. (Duffy et al., 1998; Xia & 
Whitesides, 1998). Whiteside’s work had a large impact on the microfluidics 
community. It allowed a user to design the microfluidic channels directly, using a 
CAD program. Furthermore, microfluidic devices fabricated from PDMS are 
physically robust and inexpensive, with fast and straightforward sealing of 
channels in oxidised PDMS. 
Subsequently, the group of Dr Richard D. Fair at Duke University (USA), 
published an article on the rapid actuation of discrete liquid droplets 
accomplished by direct electrical control of the surface tension (Pollack et al., 
2000). It was the first publication describing a liquid handling technology known 
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as digital microfluidics. This novel method had a massive influence on chemical 
and enzymatic reactions, DNA-based applications, immunoassays, clinical 
diagnostics, cell-based applications and proteomics, due to flexible device 
geometry, simple instrumentation, and easy integration with other technologies 
(Choi et al., 2012). 
Microfluidic devices applied in the field of microbiology offer significant 
improvement over traditional methods. Microfluidic devices are now easy to 
fabricate, require little power and require lower reagent consumption. They have 
the capability to handle high-throughput analyses and allow precise handling of 
small liquid volumes in microchannels (10–1000 μm).  
In recent years, microfluidic systems have offered an attractive method for 
automating the process of DNA and RNA extraction (Vulto et al., 2010) and for 
the preparation of DNA libraries (Yehezkel et al., 2016). Analysis of the 
phenotype and behaviour of a bacterial system can also be automated and 
carried out at the single-cell level (Guo et al., 2012). This has made microfluidics 
particularly useful for studying bacterial interactions, as a small number of cells 
can be grown under precise conditions, with tightly controlled and predictable 
fluid flow rates. In 2016, Ramalho and co-workers described a microfluidics-
based approach for the single-cell analysis of bacterial sender and receiver 
systems, based on E. coli, engineered with the quorum sensing systems of 
Aliivibrio fischeri (Ramalho et al., 2016). This approach allowed the dynamic 
response of receiver bacteria to varying amounts of the quorum sensing inducer 
N-3-oxo-C6-homoserine lactone (AHL) to be studied in terms of gene expression.  
Developing the testing of susceptibility to antibiotics in a microfluidic scale carries 
the advantage of practical sample usage, since it requires small sample 
quantities. At the same time, microfluidic devices are easily scalable to perform 
multiple tests on multiple samples (Mairhofer et al. 2009; Sauer-Budge et al. 
2009; Yager et al. 2006).  
The research of Balaban’s group led to a mathematical model which describes 
the persister phenotypic switch. They found the optimal rate of switching between 
a normal or persister cell phenotype to depend strongly on the frequency of 
environmental changes, and only weakly on the selective pressures of any given 
environment (Balaban et al., 2004; Kussell et al., 2005). More recent studies used 
a microfluidic device to show that Wild Type (WT) E. coli becomes persistent by 
temporarily switching into a slow growth state. The switch happens in rare cases 
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where a cell has a high enough level of (p)ppGpp to activate the regulatory 
cascade responsible for growth arrest (Maisonneuve et al., 2013). They also 
reveal the regulatory network behind this mechanism of switching. 
Campos et al. (2014) and Taheri-Araghi et al. (2015) used a combination of 
microfluidics and microscopy to better study single cell growth and size during a 
replication cycle. This study requires precise measurement of the size (length) of 
many cells grown under steady-state growth conditions. The two groups were 
able to maintain constant growth conditions over an extended period of time, so 
that cells could be imaged and analysed over several generations. Many cells 
were tracked simultaneously. Measurements of cell length from birth to division 
were obtained with high precision at the single-cell level. 
The microfluidic chip used by Taheri-Araghi, et al. (2015) is known as the Mother 
Machine. The Mother Machine (section 2.2.2) was developed by Jun and 
colleagues, and its design is publicly accessible on the Jun lab’s website (Taheri-
Araghi et al., 2015; Wang et al., 2010; http:// jun.ucsd.edu/, Method 1 in Section 
11). The Mother Machine has individual growth channels similar to those used by 
Balaban et al. (2004). Each chip can contain over 1000 growth channels. One 
end of each channel is closed, and the other end opens into the main channel, 
where growth medium flows through. A cell at the closed end of the growth 
channel is referred to as the ‘mother cell’. The size of the growth channels is 
designed to match the average diameter of the bacteria, to prevent the mother 
cell from moving around, making image analysis and cell tracking much easier.  
All these studies have significantly enriched microfluidics-based research. In 
particular those focused on bacterial phenotyping, and responses to external 
environmental stimuli.  
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1.5 DNA-PAINT  
 
Much of our knowledge regarding biological processes at the cellular and 
subcellular level has come from direct cell imaging. Fluorescence microscopy is 
one of the most widely used imaging techniques because of its two principal 
advantages: specific cellular components may be observed through molecule-
specific labelling, and when combined with light microscopy, allows the 
observation of structures inside a live sample in real time (Huang et al., 2008). 
However, conventional fluorescence microscopy is limited by relatively low 
spatial resolution, due to the diffraction limit of light. This limit is about 200–300 
nm in the lateral direction and 500–700 nm in the axial direction (Huang et al., 
2009). In recent years, a number of “super-resolution” fluorescence microscopy 
techniques have been invented to overcome the diffraction barrier. High-precision 
localisation of bright light sources, such as fluorescent particles, is often used in 
biophysical experiments (Mohan et al., 2013).  
 
1.5.1 Super resolution fluorescence microscopy 
 
A biological structure is defined by the positions of the atoms that build up the 
structure of the molecules. In the same way, a fluorescence image is defined by 
the spatial coordinates of the fluorophores that generate the image. The position 
of an isolated fluorophore can be precisely determined through the detection of 
the photons emitted; the more photons recorded, the more precise the 
localisation (Huang et al., 2008). Taking advantage of single-molecule detection 
and imaging (Moerner & Kador, 1989; Orrit & Bernard, 1990), nanometre-
precision in the localisation of single fluorescent molecules has also been 
achieved (Yildiz, 2003). 
When multiple molecules are present in close proximity, however, localisation 
becomes inaccurate or impossible because the images of these fluorophores 
overlap. Separation of the fluorescence signal from a few molecules with 
overlapping images may be achieved either in the spectral domain, according to 
their distinct excitation or emission spectra (Churchman et al., 2005; Lacoste et 
al., 2000; van Oijen et al., 1998) or in the time domain, taking advantage of the 
photo-bleaching (Gordon et al., 2004; Qu et al., 2004), or blinking (Lagerholm et 
al., 2006; Lidke et al., 2005) of the different emitters. It is, however, difficult to 
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scale up the number of fluorophores that can be resolved within a diffraction-
limited area using these methods.  
Molecules can ‘switch’ between fluorescence on- and off-states to obtain sub-
diffraction image resolution (Jungmann et al., 2014). This switching is traditionally 
obtained in two ways: the first, providing targeted switching, actively confines the 
fluorescence excitation to an area smaller than the diffraction limit of light, while 
in the second, switching is stochastic, making use of photo-switchable proteins 
or organic dyes.  
1.5.2 DNA-PAINT and microfluidics 
 
The technique termed universally PAINT (Point Accumulation for Imaging in 
Nanoscale Topography) achieves specific dye-sample interactions, but lacks the 
ability to specify interactions with programmable kinetics. In a similar manner to 
PAINT, DNA intercalating dyes have also been used to obtain super-resolved 
images of DNA (Flors et al., 2009; Schoen et al., 2011). Here, imaging is carried 
out using diffusing fluorescent molecules that interact transiently with the sample 
(Jungmann et al., 2014). Illustrated for the first time by Jungmann et al.,(2014), 
DNA point accumulation for imaging in nanoscale topography (DNA-PAINT) is a 
new technique developed to overcome the diffraction limit for super-resolution 
imaging. DNA-PAINT is represented by stochastic switching (Fig 1.8). Imaging is 
carried out using diffusing fluorescent molecules bonded with single stranded 
DNA (ssDNA), known as imager strands, which interact transiently with 
complementary ssDNA (docking strands). Docking strands are short, single-
stranded DNA oligomers, usually 8–10 nucleotides long. These can be fixed to a 
biological target of interest, using standard immune-labelling approaches with 
DNA-conjugated antibodies, as illustrated in Fig.1.9, targeting proteins of interest 
(Agasti et al., 2017) or direct hybridisation of docking strands to DNA or RNA 
molecules. In contrast, the imager strand is conjugated to an organic dye and 
diffuses freely in the imaging buffer. Usually, imager strands are hard to detect 
because they diffuse over many camera pixels during the duration of a single time 
frame. However, thanks to their complementary sequence, imager strands can 
transiently bind to docking strands. During the bound state, imager strands are 
fixed for an extended amount of time, allowing the camera to accumulate enough 
photons from the dye to be detected (Schnitzbauer et al., 2017). 
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Fig 1.8: DNA-PAINT concept. Transient binding of dye-labelled DNA strands (imagers) 
to their complementary target sequence (docking site) attached to a molecule of interest. 
The transient binding of imager strands is detected as ‘blinking’, illustrated by the 
intensity versus time trace (Schnitzbauer et al., 2017). Red stars represent dyes. 
 
DNA-PAINT is not prone to photobleaching as imager strands are continuously 
replenished from the solution; the binding duration depends exclusively on the 
stability of the formed DNA duplex, and can hence be programmed by modulating 
strand length, GC content, temperature or salinity of the imaging buffer. The 
affinity of imager strands for docking strands is nearly 100%, and allows 
sequential imaging of multiple targets using one dye and one laser, in fact, DNA-
PAINT does not require special experimental conditions to obtain photo-
switching, so long as probes are able to diffuse freely and reach their targets.  
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Fig. 1.9: In situ protein-labelling strategy for DNA-PAINT using primary and DNA-
conjugated secondary antibodies (Schnitzbauer et al., 2017). Red stars represent dyes. 
 
DNA-PAINT brings several advantages. First, the use of DNA-based imaging 
probes enables high multiplexing, as seen via Exchange-PAINT (Jungmann et 
al., 2014). After the first DNA-PAINT image has been acquired, the imager 
solution can be washed away with buffer and replaced by a different imager 
solution. Repeated imaging, washing and reintroduction of new imager strand 
species allows the creation of a multiplexed image of different biological targets. 
Furthermore, by programming the binding duration, an extremely high number of 
photons can be detected from a single binding (or blink) event, enabling optimal 
localisation precision. The predictability of DNA binding and unbinding events, 
combined with effectively no bleaching allows accurate quantitative imaging. 
As Jungmann demonstrated, buffers play a major role in DNA-PAINT. By 
employing a microfluidic experimental set-up, buffers can be continuously 
exchanged, and different types of imager/fluorophores can be replaced and 
tested in a fast and efficient manner. Thus, the sample is never moved from the 
stage, and all solutions are added and removed in situ, enabling systemic 
analysis of all the different combinations tested, advancing possibilities for 
technical development and novel biological applications. 
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1.6 Project aims 
 
The overall aim of this project is to develop a series of new methods which will 
allow a better understanding of antibiotic persistence and the VBNC state in the 
model bacterium E. coli. E. coli has long been one of the favoured model 
organisms in molecular and genetic studies because of the deep knowledge of 
its genome and genetic regulation mechanisms, and the ease with which it can 
be handled and studied in a laboratory setting. For this thesis, classic 
microbiological techniques have been used.  
In the first part of this project, cultures of E. coli have been treated with three 
different antibiotics: ampicillin, gentamicin and ofloxacin. These antibiotics were 
supplemented with a solution either containing fresh nutrient media or the 
medium spent by the growing bacterial culture itself, in order to study the 
formation of persister cells. Furthermore, the role of the gene ompF in the 
formation of persister cells has been investigated. In parallel to this, a microfluidic-
microscopy approach has been developed to study a cell's response to the stress 
caused by the exposure to the aforementioned antibiotics at single-cell resolution. 
The second part of this project focused on preliminary work with the technique of 
DNA-PAINT coupled with microfluidics and fluorescence microscopy. The 
sequences for docking strands and imager strands were designed, and then a 
microfluidic chip was moulded to perform an EXCHANGE-PAINT experiment.  
The rationale behind this project is to develop the techniques of DNA-PAINT, 
microfluidics, and super-resolution microscopy to study the physiology of normal, 
persister, and VBNC cells, and the phenotypic responses of these cell states to 
environmental stimuli, in this case, the presence of antibiotic compounds. Taken 
together these studies will especially enrich knowledge of persister cell formation 
providing novel and relevant information about the persister phenotype. 
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2. Materials and Methods 
 
All chemicals were obtained from Sigma-Aldrich (Irvine, UK) unless otherwise 
stated. All chemicals used were of analytical grade. All solutions were made using 
Purite double distilled purified water (ddH2O). All media and buffers used in 
microbiology were sterilised by autoclaving at 121 °C for 20 minutes at 15 psi, or 
by filter sterilisation using a Sartorius Stedim, minisart 0.2 µm single-use filter unit 
(Sartorius, Stonehouse, UK). 
 
2.1 Microbiology 
2.1.1 Growth media 
Table 2.1: Media used in this study 
E. coli Media Components (for 1 L)  
Luria-Bertani 
(LB) broth 
10 g            Tryptone 
10 g            NaCl  
5 g              Yeast extract 
LB agar 
1 L              LB Broth 
8 g              Agar 
M9 Minimal 
Medium (M9) 
12.8g          Na2HPO4·7H2O   
    OR 
6 g              Na2HPO4 (anhydrous)   
3 g              KH2PO4    
0.5 g           NaCl     
1 g              NH4Cl     
 
2.1.1.1  Spent LB 
Spent LB was made by two sequential centrifugation steps at 4000 rpm for 5 
minutes and a 0.2 µm filtration steps from an overnight culture (17 hours) before 
re-inoculation with bacterial cells. 
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2.1.2 Antibiotics 
 
Antibiotics were prepared at a 1000× concentration in ddH2O. Stocks were stored 
at -20 °C and fully defrosted before use. Three different antibiotics have been 
used: Ampicillin, Gentamicin, and Ofloxacin. Final working concentrations used 
in each assay was 25 × minimal inhibitory concentrations (MIC). Table 2.2 shows 
MIC literature versus MIC found in our laboratories through different experiments. 
Table 2.2: MIC literature versus MIC determined in our laboratories through 
different experiments.  
E. coli K-12 
BW25113  
wild-type 
Minimum inhibitory concentration (MIC) 
96-well assay  
Mean ± SEM 
MIC test strips 
Mean ± SEM 
Literature 25× MIC 
Ampicillin 
(μg/mL) 
5.00 ± 1.00 4.66 ± 1.33 
3 (“Eurofins Scientific,” 
2017) 
5 (X. Guo et al., 2013)  
2 (Ma et al., 2009) 
16(Firmino et al. 2013) 
125 
Gentamicin 
(μg/mL) 
4.00 ± 1.09 0.54 ± 0.23 
1(“Eurofins Scientific,” 
2017) 
4 (Ma et al., 2009) 
100 
Ofloxacin 
(μg/mL) 
0.125 ± 0.001 0.08 ± 0.01 
0.1 (Hansen et al. 
2008)(“Eurofins 
Scientific,” 2017)  
3.125 
 
2.1.3 Escherichia coli growth  
 
For this study, the strains Escherichia coli BW25113 (Dharmacon, Lafayette, CO, 
USA) and its knock-out derivative ΔompF were used. Luria Bertani (LB) broth and 
LB agar plates were used to culture E. coli. Overnight cultures were prepared by 
inoculating a single colony from a streak plate to 200 mL of LB broth followed by 
incubation at 37°C in a shaking incubator (250 rpm) for at least 16 hours. 
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2.1.4 Classic Microbiological assays 
2.1.4.1 Growth curve 
 
An overnight culture of E. coli was diluted 1:1000 in 100 mL LB and cultured on 
a shaker (250 rpm) at 37 ˚C for 8 hours. 500 μL of cells were transferred to an 
Eppendorf tube for each time point required and centrifuged for 5 minutes at 
13000 rpm. Then 470 μL of supernatant was removed, the cell pellets were re-
suspended in 470 μL Phosphate Buffer Solution (PBS) and serially diluted. For 
all time points required 10μL of each cells dilution was spotted on an LB agar 
plate then plates were incubated in a static incubator at 30°C for at least 16 hours 
for measuring colony forming units (CFU). Three biological replicates were 
prepared for each time point. 
The Fig. 2.1 shows the control curve of an overnight culture of WT E. coli. 
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Fig 2.1: An overnight culture of E. coli was diluted 1:1000 in LB and cultured on a shaker 
(250 rpm) at 37 ˚C for 8 hours. Data and error bars are the mean and standard error of 
the mean (SEM) of measurements obtained by using the colony forming unit (CFU) 
assay at least on biological triplicates as described in section 2.1.4.1. 
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2.1.4.2 Persister cells assay 
 
As already mentioned in the Introduction Persister cells are a subpopulation 
which is able to survive exposure to high concentrations of an antibiotic without 
devolving a resistance. To allow the selection and study of this fraction of cells 
an assay has been developed and is illustrated in the figure below. 
 
Fig. 2.2: Cartoon illustrating the persister cells assay. A single colony of E. coli grew for 
17 hours at 37 °C at 200 rpm in LB media (a). t=0 the time at which this culture was 
diluted 1:1000 in LB and growth at 37 °C and 200 rpm was restarted (b). Nine aliquots 
were taken from the growing culture every 30 minutes (c). Three aliquots were 
centrifuged immediately; the other six were treated for 3 hours, three supplemented with 
500 µl of fresh LB and three directly to the aliquot. In both cases, the final concentration 
was 25×MIC. The treated aliquots were incubated for 3 hours at 37 °C and 200 rpm, 
centrifuged 13000rpm for 5 minutes (e), re-suspended in PBS (f), serial diluted (g) and 
plated on LB agar (h). 
  
 
35 
An overnight culture of cells was diluted 1:1000 in 100 mL LB flask and cultured 
on a shaker (250 rpm) at 37˚C for 8 hours. 500 μL of cells were challenged in 
Eppendorf tube for each time point required with drug (ampicillin, gentamicin or 
ofloxacin) in LB or only drug to reach a final concentration of 25× MIC and 
incubated at 37˚C for three hours. After 3 hours of incubation with the drug, three 
aliquots were centrifuged for 5 minutes at 13000 rpm, re-suspended in PBS and 
diluted several times. For all time points required 10 μL of each cell dilution was 
spotted on an LB agar for determination of CFU then plates were incubated in a 
static incubator at 30 °C for at least 16 hours. Three biological replicates were 
prepared for each time point. 
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2.2 Microfluidics  
2.2.1 Soft Lithography 
 
Soft lithography is the general name for several different nanofabrication 
techniques such as replica moulding, micro-contact printing, micromoulding in 
capillaries, micro-transfer moulding, solvent assisted micro moulding and near-
field conformal photolithography using an elastomeric phase-shifting mask 
(Madou, 2002). All these methods use an elastomer either as the end product or 
as an intermediate step as for example as a stamp. The most common elastomer 
used is PDMS. 
In brief, a master initially is produced on a silicon wafer by one of the 
nanofabrication techniques mentioned above. The masters used in this study 
were prepared through UV-photolithography. The device layout is printed on a 
transparency or a chrome mask making some areas transparent and others 
opaque to UV-light. A silicon wafer is then spin-coated with a photocurable resist 
which is exposed to UV-light through the mask. The wafer is then subjected to an 
etching solution that removes the uncured photoresist. The master is ready to be 
used as a mould to cast a negative structure in an elastomer (Whitesides et al., 
2001). The elastomeric replica produced can be used as a component of a 
microfluidic device or as a stamp to transfer the pattern to a different material. 
The greatest advantage of soft lithography is that devices can be produced very 
quickly, at low cost and the end product often has a high quality. 
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2.2.1.1 PDMS (Polydimethylsiloxane) 
 
PDMS is a polymer which is often used for microfluidic applications. PDMS is 
flexible, optically transparent to wavelengths >230nm, impermeable to water but 
not to gases and biocompatible (Sia & Whitesides, 2003). PDMS is made up of 
repeating units of –OSi(CH3)2-. Its surface is hydrophobic in its unprocessed state 
due to the CH3 groups. This is a considerable drawback in microfluidic application 
since it renders the surface lacking in wettability with aqueous solvents and offers 
a channel surface prone to trapping air bubbles. The problem of hydrophobic 
surfaces can, however, be overcome by treating the PDMS structure with an 
oxygen plasma to render the surface hydrophilic. The mechanism behind the 
change in susceptibility to water is due to an oxidation of the surface producing 
silanol groups (Si-OH) at the surface (Bhattacharya et al., 2005). An oxidised 
PDMS surface will stay hydrophilic if kept in contact with water whereas in the air 
the hydrophobic groups will once again dominate the surface behaviour in ~30 
minutes (Sia & Whitesides, 2003). The capacity to produce hydrophilic silanol 
surface groups also enables irreversible bonding to silicon-based structures such 
as glass slides or other PDMS structures. 
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2.2.2 Device Design 
 
The microfluidic platform was designed in AutoCAD© (Autodesk, San Rafael, CA, 
USA). Several models were tested were parameters such as width and height of 
the different channels, the number of and placing of inlets and outlets, as well as 
connections between inlets and outlets and capillaries were evaluated. Here will 
be reported chips called Cell chip 2 (Fig. 2.3 ) and Mother machine chip (Fig. 2.4), 
which was already available in our laboratory. 
 
 
Fig.2.3: The Cell chip 2 design of the photomask (top) and its channels (bottom). 
Inlet Outlet 
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Fig 2.4: The Mother machine chip design. U-shaped main channel (25 µm of depth, 100 
µm of width) of which one side is equipped with 8000 lateral channels (1.5 µm of width, 
1.5 µm of depth, 25 µm of length). 
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2.2.3 PDMS chip production 
 
The designs above were transferred on photoresist-silicon masters by Dr 
Pagliara multilevel photolithography.  
2.2.3.1 Microfluidic device fabrication 
 
PDMS prepolymer (Sylgard® 184, Dow Corning, Midland, MI) and curing agent 
were carefully mixed in a 9:1 ratio and let it rest 30 minutes. The solution was 
cast over the master, let it rest for additional 30 minutes to remove all air bubbles 
and placed in an oven at 70 °C for 120 minutes. The cured PDMS replica was 
separated from the master by cutting and peeling it off, and inlets and outlets 
were created using a biopsy puncher with an inner diameter of 0.75mm (World 
Precise Instrument, Irvine, UK). The PDMS replica was irreversibly sealed on a 
glass coverslip by exposing both surfaces to oxygen plasma treatment (10 s 
exposure to 30 W plasma power, Plasma etcher, Diener, Royal Oak, MI, USA).  
 
2.2.4 Microfluidic persister assay 
2.2.4.1 Microscope setup 
 
Bright-field and fluorescence images were taken via an Inverted microscope 
(IX73 Olympus, Tokyo, Japan) at 30 minutes intervals to measure cells growth. 
The microscope was equipped with a 60× magnification, 1.2 N.A. objective 
(UPLSAPO60XW, Olympus, Tokyo, Japan) and a sCMOS camera (Zyla 4.2, 
Andor, Belfast, UK). The device was moved by two automated stages (M-
545.USC and P-545.3C7, Physik Instrumente, Karlsruhe, Germany, for coarse 
and fine movements, respectively). For fluorescence imaging, a Broad-spectrum 
LED (CoolLED pE300white, Andover, UK) and filter cubes were used. 
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2.2.4.2 Bacteria staining 
 
For monitoring the viability of single bacteria and the membrane integrity of the 
cell rapid epifluorescence staining method using the LIVE/DEAD Bacterial 
Viability Kit (Thermo Fisher Scientific, Gloucester, UK) was applied to as 
described in the protocol supplied by the manufactures. Briefly, BacLight is 
composed of two nucleic acid-binding stains: SYTO 9 and propidium iodide (PI). 
SYTO 9 penetrates all bacterial membranes and stains the cells green, while PI 
only penetrates cells with damaged membranes, and the combination of the two 
stains produces red fluorescing cells. Optimal incubation conditions were found 
to be 30 minutes, at room temperature in the dark. Total (red + green) and viable 
(green) cells can hence be counted (Boulos et al., 1999). 
 
2.2.4.3 Microfluidic-based persister assay 
 
An overnight culture of E. coli was cultured for 17 hours in LB (see section 2.1.3). 
The mother machine (MM) chip was prepared according to section 2.2.3.1. The 
oxygen plasma treatment temporarily rendered PDMS and glass hydrophilic, so 
within 5 minutes after bonding the chip was filled with 10 µL of Bovine Serum 
Albumin, BSA, (50 mg/mL). The BSA passively adsorbs on the PDMS surface 
avoid the interaction of biomolecules and microfluidic substrates (Mark et al., 
2010). The MM chip was then incubated at 37 °C for one hour thus passivating 
the device internal surface and preventing successive cell adhesion. The 
overnight culture was concentrated by centrifugation for 5 minutes at 4000 rpm, 
20°C. The cell pellet was re-suspended to a theoretical concentration of 50 OD600 
equivalents in 1 mL of spent LB. 1:100 of BSA (50 mg/mL) was added to the re-
suspended culture. 10 µL of bacteria/BSA mixture was injected into the MM chip 
and incubated in the 37 °C incubator for 20 minutes. This incubation step is 
necessary to facilitate the entrapment of bacteria cells inside the mother machine 
chip arms. The mother machine chip was connected to a Flow Unit S (Fluigent, 
Paris, France), as in Fig. 2.5, continuously measuring the flow rate through the 
device. The applied pressure was controlled by a computerised pressure-based 
flow control system (MFCS-4C, Fluigent, Paris, France) through the MAESFLO 
software (Fluigent, Paris, France).  
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Spent LB was flowed through the main channel until it cleared the excess of 
bacteria (~5 minutes at 50-250 mbar gradually over this time) shown in Fig. 2.6. 
 
 
Fig. 2.5: Microfluidics setup mounted on the automated microscope stage. The Mother 
machine inlet is connected to Flow Unit S feeding from reservoir archives. 
 
 
Fig. 2.6: Before and after washing step. Images had taken before (A) and after (B) 5 
minutes of washing at 50-250 mbar through the main channel. 
 
A B 
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Once cleaned the main channel the set up was ready for the experiment. Fresh 
LB/drugs (25×MIC) was injected through the main channel for three hours and 
images have been taken every 30 minutes (flow rate 100 µL/hr). After the 3 hours 
challenge, only fresh LB was given to the bacteria cells to let them re-grow for 
other 3 hours. Finally, PI/fresh LB and subsequently SYTO9/fresh LB were 
added. Bright-field and fluorescence images were acquired after 30 minutes of 
incubation respectively. 
 
2.2.5 Image analysis 
 
The bright field and fluorescence images acquired during and after the antibiotics 
challenge described in the previous section were analysed using the ImageJ 
software (Schneider et al. 2012). The background fluorescence of the whole field 
of view in each fluorescent channel was subtracted from the fluorescence of each 
cell, at each time point. The average fluorescence intensity of the pixels contained 
within the specified cell boundaries was determined for each cell and 
fluorescence channel. Once analysed the whole time's sequence of images was 
examined visually for cell counting. The cells were sorted based on staining and 
morphology in dividing, growing, and non-growing (viable but not culturable cells) 
cell fractions. 
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2.3 DNA PAINT 
 
2.3.1 Buffers 
 
Table 2.3: A list of the buffers used and their components, pH was adjusted to 
7.5. 
 
Buffer Composition (for 1 L) 
TE Buffer 1x  
10 mM Tris-HCl pH 8 
1 mM EDTA  
TE Buffer+1 M NaCl 
10 mM Tris-HCl pH 8 
1 mM EDTA 
1 M NaCl 
Buffer C 
100 mM Sodium Phosphate Buffer 
500 mM NaCl 
1 mM EDTA 
 
2.3.2 Oligonucleotides Design 
 
All oligonucleotides were purchased from Integrated DNA Technologies (IDT) or 
Eurofins Genomics as a salt-free pellet. Oligonucleotides were re-suspended in 
a Tris-EDTA (TE) buffer solution to make a 100 µM solution and stored at -20°C. 
The docking strands are biotinylated, while imaging is performed using imager 
strands labelled with the following dyes ATTO655 or ATTO550. 
Table 2.4: Oligonucleotides design 
 
*Bt: Biotin; A655/550: Atto655 or Atto550 
  
Docking Bt A G A T G T G A G T G A A G G A G T G T T A G A
Complementary 
Strand
T C T A C A C T C A C T T C C T C A C A A T C T
Imagers C T C A C T T C C T C A C A A T C A A655/550
Blocking Strand C T A C A C T C A C T T C C T C A
Permanently Binding
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2.3.3 DNA coating of streptavidin-functionalized colloidal particles 
 
Streptavidin-coated Polystyrene particles have been used, (from microparticles 
GmbH, Berlin, Germany), with an average diameter of 0.527 µm (10 mg/mL in 
aqueous solution), stored at 4˚C. For coating colloidal particles with DNA TE 
buffer + 10 mM NaCl, TE buffer + 100 mM NaCl, TE buffer + 1 M NaCl have been 
used. Alternatively, phosphate buffer can be used instead of TE buffer. 
 
2.3.4 Optimized coating process 
 
5 µL of colloidal particles solution have been sonicated at room temperature for 
10 minutes to break up aggregates. 100 µL of DNA docking strand @1µM (Table 
2.3.) have been defrosted and mixed into the 5 µL batch colloidal solution. DNA 
aliquots contain 100 pmoles of DNA, 4x excess compared to the binding capacity 
of the particles. DNA-batch colloidal solution has then been vortexed and 
incubated for 2 hours at RT on a shaker (to prevent sedimentation). 
Subsequently, the particles have been washed to remove unbound DNA by 
adding 400 µL of TE buffer with 10 mM NaCl. This reduces the salt concentration 
to avoid particle aggregation over the next steps. Samples have been centrifuged 
for 5 minutes at 13.6 k rpm. The supernatant has been removed but the 5 µL at 
the bottom, which should contain most of the particles. Particles have been re-
suspended the in 100 µL of 10 mM NaCl TE buffer and mixed by vortex and then 
repeated 4 times to get rid of the entire unbound DNA. The particles have been 
used within 1 or 2 days and Stored in the fridge at 4˚C. 
The NaCl concentration was increased gradually to 300 mM by adding small 
aliquots of 1 M NaCl TE buffer every 30 minutes after the beginning of the 
incubation. Higher salt concentration improves the binding of the DNA by 
screening coulomb repulsion but also favours particle aggregation via van der 
Waals.  
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2.3.5 Microfluidics chip design 
 
The microfluidic platform was designed as described in section 2.2.2. For this 
experiment, the DNA-PAINT chip A and B were designed ( fig 2.7 A and B). 
Fig.2.7: The DNA-PAINT chip design of the photomask (top) and its channels (bottom).  
 
2.3.6 Optimisation of microfluidics protocol for DNA paint 
 
Preliminary experiments and optimisation have been executed on a coverslip. 
Subsequently, a microfluidic chip was designed and moulded (Fig. 2.6). The 
DNA-PAINT chip A was prepared according to section 2.2.2. The colloidal 
particles, beads for brevity, coated with DNA (see table 2.4) were injected and let 
them settle for 30 minutes. DNA-PAINT chip A was connected to two shut off 
valve (Fig.2.8). The inlet reservoir was filled with Buffer C, which was flowed (50 
mbar) through the main channel to wash away the excess of beads. In order to 
change solution, the pressure was reduced to zero, and the imager A655 (1nM) 
(see table 2.4) was injected. Images were acquired, and then the sample was 
Outlet 
Outlet 
Inlet 
A B 
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washed through the microfluidic chip with Buffer C. Finally, the second imager, 
A550, was added, and images were acquired. 
 
Fig.2.8: Microfluidics setup for DNA-PAINT. DNA-PAINT chip attached to the shut-off 
valve, connected to the reservoir archives and microfluidics pump.  
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3. Results 
3.1 Classic Microbiological assays 
In this section the results from classic microbiology assays have be presented. 
Here the temporal windows in cell growth cycles, during which, in response to 
antibiotics a culture became enriched for persisters cells have been identified. 
Three antibiotics were tested: a β-lactam (ampicillin), an aminoglycoside 
(gentamycin) and a fluoroquinolone (ofloxacin). At first, E. coli cells were treated 
for three hours at 25× their MIC for ampicillin, gentamicin or ofloxacin, diluted in 
fresh LB medium and the corresponding fraction of persisters cell identified. 
Then, the same experiment has been performed, with the antibiotics 
supplemented with a medium spent by the growing bacterial culture itself in order 
to evaluate how the persisters fraction behaves in this stress-inducing 
environment. 
 
3.1.1 Growth stage dependent persister cells formation 
 
The E. coli culture showed a growth phase-dependent division rate (Fig. 3.1). 
After 30 minutes from dilution of an overnight culture in LB, the cell division rate 
was close to zero and then slowly increased to a maximal value of 2.8±0.4 div    
h-1 after 3.5 hours from dilution. After this time, the division rate decreased to a 
value close to zero.  
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Fig. 3.1: The bacterial division rate throughout the different stages of growth. An 
overnight culture of E. coli BW25113 was diluted 1:1000 in fresh LB. We measure 
division rate as the log 2 fold change between the bacterial colony forming unit CFU at 
consecutive hourly intervals throughout a bacterial growth cycle. Measurements and 
SEM are calculated from at least three biological and technical replicates. 
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3.1.2. Effect of the environment on persister cell formation 
 
In order to study the growth-state dependence of persistence, we used the 
protocol described in section 2.1.4.2. For this experiment, a culture of E. coli was 
treated for three hours at given time points with ampicillin, gentamicin or 
ofloxacin. We found that the absolute number of persister cells increased during 
growth and became constant as the culture entered stationary phase (Fig.3.2). 
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Fig. 3.2: Number of persister cells in a population tracked after three hours treatment 
with three different antibiotics. Dependence of the number of persister cells to ampicillin 
(red diamond), gentamicin (blue triangle), or ofloxacin (green square) on time elapsed 
from dilution in LB medium. Corresponding counts for the total number of bacteria in the 
culture before antibiotic treatment (black circles). Data and error bars are the mean and 
standard error of the mean (SEM) of measurements obtained by using the colony forming 
unit (CFU) assay at least on biological triplicates as described in section 2.1.4.2. Drugs 
were administered for three hours at 25x MIC. 
 
For each drug and each time point, we performed two different treatments as 
illustrated in Fig. 2.1 c: three culture aliquots were treated with the drug and fresh 
LB (Fig. 2.1c, ii) whereas three other aliquots were treated with drug only 
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solubilised in ddH2O (Fig. 2.1c, iii). In both cases, the final drug concentration 
was 25× the drug MIC.  
When ampicillin only was added to the culture aliquots, we measured a 1.5 log10 
fold increase in the fraction of persister cells one hour after dilution from overnight 
culture (t=1 h, Fig 3.3 open symbols). At the same time point we did not observe 
any increase of persister cells when we added ampicillin in fresh LB to the 
aliquots; however, in the same case, we measured a 2 log10 fold increase during 
the interval 4-7 hours (full symbols in Fig. 3.3).  
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Fig 3.3: Three hours treatment with ampicillin. Dependence of the number of persister 
cells to ampicillin on time elapsed from dilution in LB medium. Data and error bars are 
the mean and standard error of the mean (SEM) of measurements obtained by using the 
colony forming unit (CFU) assay at least on biological triplicates as described in section 
2.1.4.2. Drugs were administered for three hours at 25×MIC. 
 
When gentamicin only was added to the culture aliquots, the persister cells 
growth curve showed a 3.6 log10 fold increase between t=2 hours and t=3 hours, 
before remaining relatively constant for the remainder of the growth cycle (Fig 3.4 
open symbols). The fraction of persisters to gentamicin when the antibiotic was 
added with fresh LB showed a similar pattern, except for a shift of 1 hour, with a 
3.4 log10 fold increase between t=3 hours and t=4 hours. 
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Fig. 3.4: Three hours treatment with gentamicin. Dependence of the number of persister 
cells to ampicillin on time elapsed from dilution in LB medium. Data and error bars are 
the mean and standard error of the mean (SEM) of measurements obtained by using the 
colony forming unit (CFU) assay at least on biological triplicates as described in section 
2.1.4.2. Drugs were administered for three hours at 25×MIC. 
 
When ofloxacin was added to the aliquots with fresh LB there was little change in 
the persister cells throughout the growth cycle (Fig. 3.5 closed symbols). 
However, the persister fraction showed a 2.6 log10 fold increase between t=2 
hours and t=4 hours was found when ofloxacin only was added to the culture 
aliquots (Fig. 3.5 open symbols). 
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Fig 3.5: Three hours treatment with ofloxacin. Dependence of the number of persister 
cells to ampicillin on time elapsed from dilution in LB medium. Data and error bars are 
the mean and standard error of the mean (SEM) of measurements obtained by using the 
colony forming unit (CFU) assay at least on biological triplicates as described in section 
2.1.4.2. Drugs were administered for three hours at 25×MIC. 
 
The differences in the persister cells fraction between the two treatment methods 
suggest that persister formation is strongly affected by the environment. 
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3.1.3 Role of ompF on persister cell formation 
 
To evaluate the role of ompF in the formation of persister cells an E. coli knock-
out mutant ΔompF was used to repeat the three hours challenge assay. The 
ompF gene encodes one of the major outer membrane porins that have been 
associated with drug uptake (Cama et al., 2015; Delcour, 2009; Ziervogel, 2013). 
A comparison between the persister cells curve in the WT and ΔompF (Fig 3.6), 
did not show significant differences. 
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Fig. 3.6: Dependence of the number of persister cells to ampicillin on time elapsed from 
dilution in LB medium. Data and error bars are the mean and standard error of the mean 
(SEM) of measurements obtained by using the colony forming unit (CFU) assay at least 
on biological triplicates as described in section 2.1.4.2. Drugs were administered for 
three hours at 25×MIC. 
When the ΔompF was treated for three hours with gentamicin showed a similar 
pattern compared to the WT except for a steep increase shifted of 1 hour, no 
more between 3 and 4 hours but between 4 and 5 hours (Fig. 3.7). 
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Fig. 3.7: Dependence of the number of persister cells to ampicillin on time elapsed from 
dilution in LB medium. Data and error bars are the mean and standard error of the mean 
(SEM) of measurements obtained by using the colony forming unit (CFU) assay at least 
on biological triplicates as described in section 2.1.4.2. Drugs were administered for 
three hours at 25×MIC. 
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When the ΔompF was treated for three hours with ofloxacin, we recorded a 
decrease of persister fraction compared to the WT except for between 7 and 8 
hours (Fig. 3.8). 
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Fig. 3.8: Three hours treatment with ofloxacin. Dependence of the number of persister 
cells to ampicillin on time elapsed from dilution in LB medium. Data and error bars are 
the mean and standard error of the mean (SEM) of measurements obtained by using the 
colony forming unit (CFU) assay at least on biological triplicates as described in section 
2.1.4.2. Drugs were administered for three hours at 25×MIC. 
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3.1.4 Discussion 
 
The dominant model of persistence postulates that persister cells are dormant 
phenotypic variants of normal cells that form stochastically in microbial 
populations (Balaban et al., 2004; Lewis, 2010; Maisonneuve et al., 2013). 
Persister cells can also arise in response to a number of environmental 
conditions, including nutrient limitation (Maisonneuve & Gerdes, 2014) and 
nutrient transitions (Amato et al., 2013). During bacterial growth, such 
environmental conditions are constantly changing, and in addition to this, a 
population can generate its own native stress, such as nutrient exhaustion or 
environmental acidification. However, increasing evidence now suggests that 
only specific environments favour persister cell formation (Amato et al., 2013; 
Bernier et al., 2013; Keren et al., 2004; Vega et al., 2012). 
Results presented here identify the temporal windows in cell growth cycles during 
which, in response to antibiotics a culture became enriched for persister cells 
(Fig. 3.2). Three antibiotics of different classes of antibiotic were tested: a β-
lactam (ampicillin), a fluoroquinolone (ofloxacin) and an aminoglycoside 
(gentamycin). At first, E. coli cells were treated for three hours at 25× their MIC 
for ampicillin, gentamicin or ofloxacin, diluted in fresh LB medium and the 
corresponding fraction of persister cells identified. Following this, the same 
experiment was performed, with the antibiotics supplemented with a medium 
spent by the growing bacterial culture itself, in order to evaluate how the persister 
fraction behaves in this stress-inducing environment. From the results shown in 
Fig. 3.3 and 3.5, what emerges is that cells treated with antibiotics, but without 
fresh media regrow at higher density than the cells in the nutrient rich 
environment. This trend is more evident in treatment with ampicillin and ofloxacin. 
The comparison between our two treatments helped to understand the 
importance of the medium composition to the response of sub-populations of 
bacteria to the antibiotic treatments. Indeed, drug treatment with fresh LB might 
alter the native culture environment, making cells more active and more 
susceptible to the drugs. Finally, the role of ompF was studied using an E. coli 
knock out ΔompF. The ompF gene encodes for one of the major outer membrane 
porins associated with drug uptake (Cama et al., 2015; Delcour, 2009; Ziervogel, 
2013). It could be hypothesised that the absence of ompF may lead to a reduced 
drug uptake and increased survival to drug treatment. However, our data do not 
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show substantial differences between ΔompF and WT populations under the 
investigated conditions (Fig. 3.6, 3.7 and 3.8).  
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3.2 Microfluidics 
 
3.2.1 Microfluidic-based persister assay 
 
In order to study the persister cell formation by using a microfluidic chip, cells 
from a stationary phase culture were introduced into the Mother Machine device. 
The first phase of the experiment (Fig. 3.9 t=0), cells moved from the main 
channel to the side arms. As soon as the cells settled in the arms (usually within 
20 minutes), spent media (section 2.1.1.1) was injected by applying an external 
pressure (50 to 250 mbar) to remove the excess cells. It is worth to point that with 
the present technology we are not completely able to control the number of cells 
trapped in our microfluidic. The number of cells trapped in each experiment has 
been specified in Table 3.1. In the next step, cells were treated with a 25× MIC 
concentration of antibiotics (ampicillin, gentamicin or ofloxacin) for 3 hours to 
isolate persister cells (Fig 3.9 t=0, t=180 minutes). Image analysis revealed that 
a few cells began to elongate after 90 minutes (Fig. 3.9 t=90 minutes), while 
others started to lyse after 180 minutes of treatment with ampicillin. During 
treatment with ofloxacin cells started to elongate after 60 minutes (Fig. 3.11 t=60 
minutes), while after 3 hours of gentamicin cells neither grew nor elongated (Fig. 
3.10 t=180 minutes). To evaluate the cell's response to a challenge of three hours 
of incubation with the different antibiotics, the cells were observed for further three 
hours after the removal of the antibiotics (ampicillin, gentamicin or ofloxacin), 
during which fresh LB medium was injected continuously (Fig 3.9 t=360 minutes). 
After 150 minutes, those cells that already had begun to elongate finally divided 
to produce a micro-colony (Fig 3.9 t=360 minutes). Cells treated with ofloxacin 
also elongated during washing with LB medium (Fig. 3.11 t=360 minutes), while 
cells treated with gentamicin neither grew nor elongated (Fig. 3.10 t=360 
minutes). The last step was to distinguish live cells from dead cells by live/dead 
staining (Fig. 3.9 t=420 minutes). Image analysis revealed that after treatment in 
the presence of ampicillin, 89% of the cells lysed, 6.7% divided, 2.1% elongated, 
and 2.2% showed no growth. During gentamicin treatment only 59.6% lysed and 
40.4% neither divided nor elongated. During the treatment with ofloxacin, 55.7% 
of cells were registered as susceptible, 0.4% as dividing, 20.7% as elongating, 
and 23.2% as non-growing cells. This is shown in Table 3.2, with a comparison 
between bulk and microfluidics studies. 
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Fig. 3.9: Exponentially growing cells of E. coli BW25113 analysed by microfluidics under 
the effect of ampicillin (see section 2.2.4.3). Time-lapse microscopy images are showing 
a single growth-arrested and resuscitation cell (white arrow), lysing cells and not lysed 
but dead cell (golden arrow) during the ampicillin (LB/ampicillin 25× MIC) treatment. 
(scale bar, 10 µm) (t = time in minutes). 
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Fig. 3.10: Exponentially growing cells of E. coli BW25113 analysed by microfluidics under 
the effect of gentamicin (see section 2.2.4.3). Time-lapse microscopy images are 
showing a single growth-arrested cell but alive (white arrow), growth-arrested cell dead 
(gold arrow) after the gentamicin (LB/gentamicin; 25× MIC) treatment. (scale bar, 10 µm) 
(t = time in minutes). 
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Fig 3.11: Exponentially growing cells of E. coli BW25113 analysed by microfluidics under 
the effect of ofloxacin (see section 2.2.4.3). Time-lapse microscopy images are showing 
a single elongating cell (red arrow); not lysed but dead cell (golden arrow) during the 
ofloxacin (LB/ofloxacin; 25× MIC) treatment. (scale bar, 10 µm) (t = time in minutes). 
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Table 3.1: Comparison between bulk studies and Microfluidics studies 
 
*CFU from a 17 hours culture on LB agar plate; **Microfluidics studies  
  
Planktonic 
growth 
(Cell fraction) 
Microfluidic growth 
(Cell fraction) 
Drug 
Average 
dividing cells* 
Average 
dividing cells** 
Average 
susceptible cells** 
Average 
elongating cells** 
Average non-
growing cells ** 
Average number of 
cells/ experiment 
Average cell 
number/channel 
Ampicillin 0.187 ± 0.012 0.067 ± 0.014 0.89 ± 0.012 0.021 ± 0.004 0.022 ± 0.01 710 0.497 ± 0.082 
Gentamicin 0.007 ± 0.072 0 0.596 ± 0.033 0 0.404 ± 0.041 1807 1.230 ± 0.041 
Ofloxacin 0.001 ± 0.047 0.004 ± 0.002 0.557 ± 0.152 0.207 ± 0.066 0.232 ± 0.103 1015 0.689 ± 0.122 
Control N/A 0.950 ± 0.359 0 0.014 ± 0.006 0.034 ± 0.013 722 0.448 ± 0.169 
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3.2.2 Discussion 
 
The work presented here shows a new way to study persister cells by using 
bespoke microfluidics, especially by exploiting the Mother Machine chip to trap 
cells and allow phenotypic analysis at the single-cell level. Indeed, with standard 
microbiological techniques we can only measure the persister fraction as shown 
in Table 3.1, while the combination of microfluidics and microscopy permits us to 
be able to distinguish additional phenotypes, such as elongating cells (Fig.3.11) 
or non-growing cells (also called VBNC cells) (Fig. 3.10). This last phenotype is 
very difficult to isolate. VBNC cells are non-dividing and, unlike persister cells, 
are unable to immediately regain the ability to divide when plated on routine 
laboratory medium (Ramamurthy et al., 2014). VBNC cells were thought to be 
formed after longer periods of incubation in environmental conditions that do not 
sustain growth. However, a recent study (Ayrapetyan et al., 2015) revealed that 
VBNC cells can exist together with persister cells in unstressed growing cultures.  
Here, three classes of antibiotics have been used to investigate cellular response 
after three hours of treatment. Although the average number of cells trapped is 
different for each experiment a trend was observed. Unsurprisingly by comparing 
the average dividing cells of the control to the average dividing cells treated with 
the antibiocts the latter resulted to be at least 10 times less numerous than the 
control (Table 3.1). 
Looking at the other data available in Table 3.1 it was possible to note some 
effects of the different antibiotics on the cells metabolism. In particular, it was 
observed that a higher percentage (6.4%) of dividing cells occurred during 
treatment with ampicillin. Ampicillin acts as an irreversible inhibitor of the 
enzyme transpeptidase, and inhibits the final stage of bacterial cell wall 
synthesis, ultimately leading to cell lysis. Therefore, it was easy to detect lysed 
bacteria trapped in the Mother Machine arms. Antibiotics like gentamicin act as 
protein synthesis inhibitors, thus a microfluidics experiment registered a higher 
percentage of non-growing bacteria (40%), while ofloxacin acts as an enzyme 
inhibitor on DNA replication, causing bacteria to elongate or enter a non-growing 
state (20% and 23% of the population, respectively). This continues until the cells 
translate all the mRNA available into the cytosol, rendering the cell is unable to 
grow and replicate, resulting in cell death. Is it possible to observe a small portion 
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of elongating and non-growing cells also in the control, this is possibly explained 
by the bet-hedging reported in section 1.1.3. 
One of the current limitations in our understanding of persister cells, is that with 
classic microbiological techniques analysis can only be carried out after treatment 
with antibiotics, not before, due to a lack of biomarkers to isolate persister cells 
from the total percentage of susceptible cells in a population before the antibiotic 
challenge. Moreover with the classic microbiology techniques it is impossible to 
identify the different cells behaviour. Indeed in Table 3.1 the number of cells in 
planktonic growth includes all the alive cells that can be distinguished into non-
growing and elongating by the application of our microfluidic technique. 
 It is worth remembering that persister cells are phenotypic variants produced 
stochastically in a population of cells, and also that their relative abundance can 
rise, reaching 1%, at the mid to late-exponential phase of growth (2.5 to 5 hours 
for E. coli) (Keren et al., 2004). We also know that they are able to spontaneously 
switch between persistent and susceptible state regaining sensitivity to 
antibiotics. Upon switching back, they appear indistinguishable from normal cells 
(Kussell et al., 2005). Thus cultures grown from persister cells are as sensitive to 
drugs as the parental culture from which the persisters were derived (Lewis, 
2010; Moyed & Bertrand, 1983; Peng et al., 2016). Recent studies (Balaban et 
al., 2013; Maisonneuve & Gerdes, 2014; Harms et al., 2016) suggest that the 
reversible adoption of a slowly-growing or non-growing state is regarded as a 
general strategy of persistence. 
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3.3 Preliminary results from DNA-PAINT 
 
In this section, the possible application of DNA-PAINT combined with 
microfluidics has been explored. In this case an example of Exchange PAINT will 
be described. As mentioned in the introduction, DNA-PAINT is a method that 
exploits programmable transient hybridisation between short single-stranded 
oligonucleotide strands, allowing multiplexed, single-molecule and single-label 
visualisation down to a resolution of ~ 5-10 nm. 
For this work, small beads (5 µm) were coated with the desired docking strands 
(Table 2.4) following the process described in section 2.3.4 and two different 
imagers were used to show the “Exchange” into a microfluidic chip. 
As mentioned before, docking strands are short, single-stranded DNA oligomers, 
usually 8–10 nucleotides long. In contrast, the imager strand is conjugated to an 
organic dye and diffuses freely in the imaging buffer. Thanks to their 
complementary sequence, imager strands can transiently bind to docking 
strands. During the bound state, imager strands are fixed for an extended amount 
of time, allowing the camera to accumulate enough photons from the dye to be 
detected (Schnitzbauer et al., 2017). The beads coated with DNA were injected 
and allowed to settle in the main channel for 30 minutes (Fig 3.12 A). The inlet 
reservoir was filled with Buffer C (table 2.3), and flowed through the main channel 
to wash away excess beads at 50 µL/hr (Fig 3.12 B). Thus, only well attached 
beads remained into the microfluidics chip and a solution containing the first 
imager (A650, Table 2.4) was flowed. A bright field and a fluorescent image were 
acquired (Fig. 3.12 C and D). Then the sample was washed through the 
microfluidic chip with Buffer C to wash away A650. To demonstrate that 
Exchange-PAINT is possible with our microfluidic chip, a second imager, A550 
(Table 2.4) was added, and images were acquired in bright field and in 
fluorescence (Fig 3.12 E and F). As expected the beads remained in their position 
and the second imager was able to interact with the docking strand taking the 
place of the first imager, showing that is possible an “Exchange” between the two 
imagers. Indeed, this it’s clearly observable in Fig 3.12 D and Fig 312 F which 
show the same fluorescent pattern, suggesting a successful exchange between 
the two imagers. 
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Fig. 3.12: Exchange-PAINT. The beads labelled with docking strands are injected into 
the microfluidic and let them settle for 30 minutes (A). Buffer C was flowed (50 µL/hr) 
through the main channel to wash away the excess of beads (B). Brightfield after the 
addition of the imager A650 (C). The fluorescence was acquired (D). After the 
acquisition, A650 strands are washed out and exchanged with imager strands A550 (E 
and F) brightfield and fluorescence respectively. Scale bar: 10µm. 
 
These preliminary results demonstrate the possibility of combining microfluidics 
and DNA PAINT, to allow control over the sample environment during imaging. 
By linking docking strands to antibodies, DNA-PAINT can be applied to many in 
vitro and cellular applications. Furthermore, its simplicity enables both novices 
and expert users to obtain high-quality results quickly. The next step would be to 
move combine this technique with in situ super-resolution microscopy. 
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4. Summary and future work  
 
Specific environments favour persister cells formation (Amato et al., 2013; 
Bernier et al., 2013; Keren et al., 2004; Vega et al., 2012). In this work, the 
temporal windows, in the growth cycle, in which the culture becomes enriched for 
persister cells to a β-lactam, a fluoroquinolone and an aminoglycoside (Fig. 3.2) 
were identified. The importance of the medium composition was investigated by 
comparing two treatments, in the presence and absence of fresh LB medium. The 
drug treatment with fresh LB altered the native culture environment. For this 
reason, the next step will be testing different condition such as nutrient transitions 
and environmental acidification. Moreover, the importance of the treatment 
duration will be tested by increasing the incubation time with the antibiotics to 24 
hours. 
Microfluidics studies showed the importance of continuous imaging of single 
cells. During this work, a protocol for performing persister cell assays in the chip 
was optimised. The Mother Machine chip is able to trap bacteria allowing 
microscopic analysis of the persistence phenotype at the single-cell level. Thanks 
to the microfluidics a complete control over the environmental conditions was 
achieved while keeping track of single cells. Future works will include the study 
of metabolic activity, the replication of the starvation studies with microfluidics 
and the identification (and isolation) of persister cells without drugs challenge.  
The preliminary data on DNA-PAINT combined with microfluidics showed that the 
Exchange-PAINT is possible also with our microfluidic device. The next step will 
be to adapt the microfluidics setup to a Super-resolution microscope. This will 
deepen the study of putative persistence protein targets to better understand the 
molecular mechanisms underlying persistence. Moreover, several in vitro 
experiments could be designed: from localisation of a specific gene to the 
identification of a target protein. Once improved the protocol increasingly detailed 
molecular studies opening the way to multiple molecular biology and cellular 
application. 
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